These results emphasize the unique nature of pathogenic UBQLN2 mutations and argue against a generalizable link between aggregation propensity and neurodegeneration in UBQLN2-linked ALS/FTD. This evidence concerns the gene UBQLN2 and amyotrophic lateral sclerosis.